PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 10, 2016Blood1,590 citationsOpen Access

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

JEJean‐François EmileOAOussama AblaSFSylvie Fraitag

Key Points

  • To update the diagnostic classification of histiocytoses and related neoplasms by integrating contemporary histological, phenotypic, molecular, and clinical findings.
  • Synthesized molecular pathology, cellular lineage origins, histology, and clinical-imaging features developed since the original 1987 classification.
  • Formulated updated diagnostic criteria and diagnostic guidelines for histiocytic diseases.
  • Categorized more than 100 distinct histiocytic subtypes into a revised five-group schema based on histology, phenotype, molecular changes, and clinical manifestations.
  • Defined five main diagnostic groups: Langerhans-related, cutaneous and mucocutaneous, malignant histiocytoses, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis with macrophage activation syndrome.

Abstract

The histiocytoses are rare disorders characterized by the accumulation of macrophage, dendritic cell, or monocyte-derived cells in various tissues and organs of children and adults. More than 100 different subtypes have been described, with a wide range of clinical manifestations, presentations, and histologies. Since the first classification in 1987, a number of new findings regarding the cellular origins, molecular pathology, and clinical features of histiocytic disorders have been identified. We propose herein a revision of the classification of histiocytoses based on histology, phenotype, molecular alterations, and clinical and imaging characteristics. This revised classification system consists of 5 groups of diseases: (1) Langerhans-related, (2) cutaneous and mucocutaneous, and (3) malignant histiocytoses as well as (4) Rosai-Dorfman disease and (5) hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Herein, we provide guidelines and recommendations for diagnoses of these disorders.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Emile et al. (2016) studied this question.

synapsesocial.com/papers/69d70eb91a8b22ff6fab31fchttps://doi.org/10.1182/blood-2016-01-690636
Ask AI
Helpful
Bookmark
Share
View Full Paper